AVNS

AVNS R&D to Revenue

3.29%Fiscal year

Period ending:

AVNS FY R&D/Revenue%
AVNS FY R&D/Revenue7.37%1.29%
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

AVNS r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Avanos Medical Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
3.2944%
3.8092%
4.0398%
4.473%
4.3379%
4.8825%
5.4042%
6.4081%
6.2459%
6.7821%
2.0516%
2.0094%
2.2593%
1.9596%
1.8796%

Compare r&d to revenue

All AVNS financial metrics · AVNS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.